首页> 外文期刊>Journal of the European Academy of Dermatology and Venereology: JEADV >Screening of Chlamydia trachomatis urogenital infections among the male and female population of the Republic of Macedonia.
【24h】

Screening of Chlamydia trachomatis urogenital infections among the male and female population of the Republic of Macedonia.

机译:马其顿共和国男性和女性人群中沙眼衣原体泌尿生殖道感染的筛查。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Noninvasive urine screening for Chlamydia trachomatis infections offers a valuable public health tool, that could be of vast importance in Chlamydia control programs. OBJECTIVE: The goal was to determine the prevalence of C. trachomatis infections among a sexually active population, to define the epidemiological factors associated with it, and to develop potential selective screening strategies among asymptomatic individuals in the Republic of Macedonia, using a highly sensitive and specific DNA amplification method for C. trachomatis. STUDY DESIGN: A total of 1435 urine samples, divided into two main groups: asymptomatic individuals (n = 1210) and symptomatic patients (n = 225), were tested. Samples from the asymptomatic group were collected during routine screening programs, while the symptomatic group consisted of patients with symptoms of urogenital tract infection, attending sexually transmitted diseases (STD) clinics. The presence of C. trachomatis was determined using commercial AMPLICOR C. trachomatis Assay (Roche Diagnostic Systems, Inc., Branchburg, NJ, USA). RESULTS: The prevalence of C. trachomatis infections among different groups was: recruits 0%, soldiers 0.4%, policemen 3.5%, clerks 4.6%, pregnant women 4%, and students 4.4%. The average prevalence for both groups (asymptomatic and symptomatic) was 2.3%[95% confidence interval (CI): 1.5-3.1%]. The average prevalence for the asymptomatic group was 1.6% (95% CI: 0.8-2.4%), while the average prevalence for the symptomatic group was 6.2% (95% CI: 3.1-9.3%) which were significantly different (P = 0.00003). CONCLUSION: Testing first void urine specimens by AMPLICOR C. trachomatis assay is a highly sensitive and specific method for diagnosing C. trachomatis infections in men and women. This method provides health care workers and public health officials with a new molecular amplification assay that uses noninvasive urine specimens for population-based screening purposes. The prevalence of C. trachomatis was relatively low among asymptomatic individuals. However, selective screening strategies are highly recommended for testing the student population in the Republic of Macedonia.
机译:背景:针对沙眼衣原体感染的无创尿液筛查提供了宝贵的公共卫生工具,这在衣原体控制计划中可能具有极其重要的意义。目的:目标是确定马萨诸塞州性活跃人群中沙眼衣原体感染的患病率,确定与之相关的流行病学因素,并在马其顿共和国无症状人群中采用高度敏感和沙眼衣原体的特异性DNA扩增方法。研究设计:共检测了1435份尿液样本,分为两个主要组:无症状个体(n = 1210)和有症状患者(n = 225)。无症状组的样本是在常规筛查程序中收集的,而有症状组则由有泌尿生殖道感染症状的患者组成,就诊于性传播疾病(STD)诊所。使用商业的AMPLICOR沙眼衣原体测定法(Roche Diagnostic Systems,Inc.,Branchburg,NJ,美国)确定沙眼衣原体的存在。结果:不同人群中沙眼衣原体感染的流行程度为:新兵0%,士兵0.4%,警察3.5%,文员4.6%,孕妇4%,学生4.4%。两组(无症状和有症状)的平均患病率为2.3%[95%置信区间(CI):1.5-3.1%]。无症状组的平均患病率为1.6%(95%CI:0.8-2.4%),而有症状组的平均患病率为6.2%(95%CI:3.1-9.3%),差异有统计学意义(P = 0.00003 )。结论:通过AMPLICOR沙眼衣原体检测法检测第一个空尿标本是诊断男性和女性沙眼衣原体感染的高度灵敏和特异的方法。此方法为医护人员和公共卫生官员提供了一种新的分子扩增测定法,该测定法使用无创尿液样本进行基于人群的筛查。无症状个体中沙眼衣原体的患病率相对较低。但是,强烈建议采用选择性筛选策略来测试马其顿共和国的学生人数。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号